Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ORCHAR    

ORCHAR

 SummaryNewsRatingsCompany 
Company
Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. The Company is engaged in the development, manufacturing and commercialization of gene and cell therapies, position to provide potentially transformative therapies to patients suffering from a broad range of rare diseases. The Company is initially focused on its autologous ex vivo gene therapy... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Notations Surperformance© of ORCHAR
Trading Rating : Investor Rating :
More Ratings
All news about ORCHAR
08/25ORCHAR : Orchard Therapeutics Announces Clinical Data Presentations at the 46th ..
AQ
08/24Orchard Therapeutics Announces Clinical Data Presentations at the 46th Annual..
GL
08/06ORCHAR : ORCHARD THERAPEUTICS PLC Management's Discussion and Analysis of Financ..
AQ
08/06ORCHARD THERAPEUTICS PLC : Results of Operations and Financial Condition, Financ..
AQ
08/06Orchard Therapeutics Advances New Strategic Plan and Reports Second Quarter 2..
GL
08/04Orchard Therapeutics to Present at Wedbush PacGrow Healthcare Virtual Confere..
GL
07/30Orchard Therapeutics to Webcast Conference Call of Second Quarter 2020 Financ..
GL
07/20ORCHARD THERAPEUTICS PLC : Other Events, Financial Statements and Exhibits (form..
AQ
07/20Orchard Therapeutics Announces Orphan Drug and Rare Pediatric Disease Designa..
GL
07/15GLAXOSMITHKLINE : Orchard in License Agreements for Stable Cell Line Technology ..
DJ
07/15ORCHARD THERAPEUTICS PLC : Other Events, Financial Statements and Exhibits (form..
AQ
07/15Orchard Therapeutics Announces Global License Agreements for Stable Cell Line..
GL
07/09ORCHARD THERAPEUTICS PLC : Entry into a Material Definitive Agreement, Other Eve..
AQ
07/09Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufactur..
GL
06/19ORCHARD THERAPEUTICS PLC : Amendments to Articles of Inc. or Bylaws; Change in F..
AQ
More news
News in other languages on ORCHAR

- No features available -

More news
Managers
NameTitle
Bobby Gaspar Chief Executive Officer & Executive Director
Frank E. Thomas President, COO, CFO & Chief Accounting Officer
James A. Geraghty Chairman
Andrea Spezzi Chief Medical Officer
Ran Zheng Chief Technical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ORCHAR0.00%431
JOHNSON & JOHNSON-0.14%383 497
ROCHE HOLDING AG5.40%304 339
MERCK & CO., INC.-8.82%209 750
PFIZER, INC.-7.99%200 326
NOVARTIS AG-12.61%190 402